tradingkey.logo

Xtant Medical Holdings Inc

XTNT
0.591USD
+0.030+5.23%
終値 02/06, 16:00ET15分遅れの株価
82.78M時価総額
45.70直近12ヶ月PER

Xtant Medical Holdings Inc

0.591
+0.030+5.23%

詳細情報 Xtant Medical Holdings Inc 企業名

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Xtant Medical Holdings Incの企業情報

企業コードXTNT
会社名Xtant Medical Holdings Inc
上場日Jun 30, 2010
最高経営責任者「CEO」Browne (Sean E)
従業員数217
証券種類Ordinary Share
決算期末Jun 30
本社所在地664 Cruiser Lane
都市BELGRADE
証券取引所NASDAQ OMX – NASDAQ Basic Amex
United States of America
郵便番号59714
電話番号14063880480
ウェブサイトhttps://xtantmedical.com/
企業コードXTNT
上場日Jun 30, 2010
最高経営責任者「CEO」Browne (Sean E)

Xtant Medical Holdings Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.52M
+553797.00%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
914.12K
+158228.00%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
566.93K
-8084.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
+158228.00%
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--
Ms. Lori D. Mitchell-Keller
Ms. Lori D. Mitchell-Keller
Independent Director
Independent Director
--
--
Mr. Tyler P. Lipschultz
Mr. Tyler P. Lipschultz
Director
Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
7.52M
+553797.00%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
914.12K
+158228.00%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
566.93K
-8084.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
+158228.00%
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Orthobiologics
17.15M
51.57%
Spinal implant
10.62M
31.94%
License revenue
5.48M
16.49%
地域別USD
会社名
収益
比率
United States
30.31M
91.15%
Rest of World
2.94M
8.85%
事業別
地域別
事業別USD
会社名
収益
比率
Orthobiologics
17.15M
51.57%
Spinal implant
10.62M
31.94%
License revenue
5.48M
16.49%

株主

更新時刻: Sat, Nov 22
更新時刻: Sat, Nov 22
株主統計
種類
株主統計
株主統計
比率
Nantahala Capital Management, LLC
48.85%
Lytton (Laurence W)
6.76%
Vizirgianakis (Stavros G)
5.37%
AWM Investment Company, Inc.
4.71%
The Vanguard Group, Inc.
1.62%
他の
32.69%
株主統計
株主統計
比率
Nantahala Capital Management, LLC
48.85%
Lytton (Laurence W)
6.76%
Vizirgianakis (Stavros G)
5.37%
AWM Investment Company, Inc.
4.71%
The Vanguard Group, Inc.
1.62%
他の
32.69%
種類
株主統計
比率
Hedge Fund
49.59%
Individual Investor
16.45%
Investment Advisor/Hedge Fund
5.20%
Investment Advisor
2.29%
Research Firm
0.04%
他の
26.42%

機関投資家保有株

更新時刻: Wed, Jan 21
更新時刻: Wed, Jan 21
報告期間
機関投資家数
保有株式数
比率
変動額
2026Q4
41
80.10M
114.61%
--
2025Q4
60
79.99M
57.14%
-82.24M
2025Q3
58
80.07M
57.19%
-75.11M
2025Q2
66
93.42M
67.06%
-16.04M
2025Q1
66
107.33M
77.15%
-2.25M
2024Q4
65
107.45M
77.30%
-1.32M
2024Q3
60
109.08M
78.63%
+8.43M
2024Q2
61
99.68M
76.50%
-1.69M
2024Q1
63
100.56M
77.45%
+777.79K
2023Q4
59
100.17M
77.23%
+1.05M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Nantahala Capital Management, LLC
68.39M
48.85%
--
--
Sep 30, 2025
Lytton (Laurence W)
9.46M
6.76%
+9.46M
--
Apr 15, 2025
Vizirgianakis (Stavros G)
7.52M
5.37%
+553.80K
+7.95%
Nov 15, 2025
AWM Investment Company, Inc.
6.59M
4.71%
-2.50K
-0.04%
Sep 30, 2025
The Vanguard Group, Inc.
2.36M
1.68%
+104.16K
+4.63%
Sep 30, 2025
Browne (Sean E.)
1.94M
1.39%
+394.94K
+25.57%
Nov 15, 2025
Beeson (Jonn R.)
1.53M
1.09%
+158.23K
+11.51%
Nov 15, 2025
Bakewell (John K)
1.07M
0.77%
+316.46K
+41.87%
Nov 15, 2025
Renaissance Technologies LLC
713.91K
0.51%
+63.20K
+9.71%
Sep 30, 2025
Neils (Scott C)
575.01K
0.41%
+263.29K
+84.46%
Nov 15, 2025
詳細を見る

関連ETF

銘柄名
比率
データなし

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI